Araya Natsumi, Sato Tomoo, Ando Hitoshi, Tomaru Utano, Yoshida Mari, Coler-Reilly Ariella, Yagishita Naoko, Yamauchi Junji, Hasegawa Atsuhiko, Kannagi Mari, Hasegawa Yasuhiro, Takahashi Katsunori, Kunitomo Yasuo, Tanaka Yuetsu, Nakajima Toshihiro, Nishioka Kusuki, Utsunomiya Atae, Jacobson Steven, Yamano Yoshihisa
J Clin Invest. 2014 Aug;124(8):3431-42. doi: 10.1172/JCI75250. Epub 2014 Jun 24.
Human T-lymphotropic virus type 1 (HTLV-1) is linked to multiple diseases, including the neuroinflammatory disease HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and adult T cell leukemia/lymphoma. Evidence suggests that HTLV-1, via the viral protein Tax, exploits CD4+ T cell plasticity and induces transcriptional changes in infected T cells that cause suppressive CD4+CD25+CCR4+ Tregs to lose expression of the transcription factor FOXP3 and produce IFN-γ, thus promoting inflammation. We hypothesized that transformation of HTLV-1-infected CCR4+ T cells into Th1-like cells plays a key role in the pathogenesis of HAM/TSP. Here, using patient cells and cell lines, we demonstrated that Tax, in cooperation with specificity protein 1 (Sp1), boosts expression of the Th1 master regulator T box transcription factor (T-bet) and consequently promotes production of IFN-γ. Evaluation of CSF and spinal cord lesions of HAM/TSP patients revealed the presence of abundant CD4+CCR4+ T cells that coexpressed the Th1 marker CXCR3 and produced T-bet and IFN-γ. Finally, treatment of isolated PBMCs and CNS cells from HAM/TSP patients with an antibody that targets CCR4+ T cells and induces cytotoxicity in these cells reduced both viral load and IFN-γ production, which suggests that targeting CCR4+ T cells may be a viable treatment option for HAM/TSP.
人类嗜T淋巴细胞病毒1型(HTLV-1)与多种疾病相关,包括神经炎性疾病HTLV-1相关脊髓病/热带痉挛性截瘫(HAM/TSP)以及成人T细胞白血病/淋巴瘤。有证据表明,HTLV-1通过病毒蛋白Tax利用CD4+T细胞的可塑性,并在受感染的T细胞中诱导转录变化,导致抑制性CD4+CD25+CCR4+调节性T细胞(Tregs)失去转录因子FOXP3的表达并产生IFN-γ,从而促进炎症。我们推测,将HTLV-1感染的CCR4+T细胞转化为Th1样细胞在HAM/TSP的发病机制中起关键作用。在此,我们使用患者细胞和细胞系证明,Tax与特异性蛋白1(Sp1)协同作用,增强了Th1主调节因子T盒转录因子(T-bet)的表达,从而促进了IFN-γ的产生。对HAM/TSP患者的脑脊液和脊髓病变进行评估发现,存在大量共表达Th1标志物CXCR3并产生T-bet和IFN-γ的CD4+CCR4+T细胞。最后,用一种靶向CCR4+T细胞并在这些细胞中诱导细胞毒性的抗体处理来自HAM/TSP患者的分离外周血单核细胞(PBMCs)和中枢神经系统(CNS)细胞,可降低病毒载量和IFN-γ的产生,这表明靶向CCR4+T细胞可能是HAM/TSP的一种可行治疗选择。